Harris, Lauren http://orcid.org/0000-0003-3255-7033
Poorthuis, Michiel H. F.
Grover, Patrick
Kitchen, Neil
Al-Shahi Salman, Rustam
Article History
Received: 19 November 2020
Revised: 21 March 2021
Accepted: 17 June 2021
First Online: 30 June 2021
Declarations
:
: Not required.
: Not applicable.
: Not applicable.
: RASS reports funding paid to his employer for a consultancy with Recursion Pharmaceuticals and funding from the National Institute for Health Research (NIHR128694) for the Cavernomas A Randomised Effectiveness (CARE) pilot trial. Other authors report no disclosures or conflict of interests.